Device Trial Radar · NCT01656174
Procleix® Dengue Virus Assay Testing of Individual Donor Samples From Puerto Rican Blood Donors - American Red Cross
Last checked: Nov 19, 2026Latest source record: Mar 20, 2015 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
35,035
Actual
Start
Aug 2012
Primary completion
Dec 2014
Study completion Jan 2015
Sponsor
- Lead sponsor
- Gen-Probe, IncorporatedNot on our public-company list
- Sponsor type
- Industry
- First posted
- Aug 2, 2012
Design
- Study type
- Observational
- Who can join
- All sexes
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The objective of this study is to test individual donor samples (IDSs) with the investigational Dengue Assay on the TIGRIS System and to further characterize the Dengue Assay in the clinical setting.
Conditions
- Dengue
Interventions
Procleix Dengue Virus AssayDevice
in vitro diagnostic assay
Primary outcomes
What the sponsor says the trial is designed to measure.
- Qualitative detection of ribosomal RNA from Dengue Virus in plasma specimens from individual human donors, including volunteer donors of whole blood and blood components, and other living donors.Time frame: Approximately three years
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Creative Testing Solutions
Tempe, Arizona
American Red Cross National Testing Laboratory
Charlotte, North Carolina
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.